BioLife Solutions, Inc. (BLFS): 10% owner sold ~$12.2M
Casdin Partners Master Fund, 10% owner at BioLife Solutions, Inc., sold ~$12.2M of BioLife Solutions, Inc. shares.
- ~$12.2M
- Approx. value · 500K sh @ $24.40
- 6.71M
- Holds after · shares reported
- Traded
- Aug 15, 2025
- Filed
- Aug 22, 2025
What stands out in this filing
- After this sale the filing reports 6,707,165 shares, held indirectly.
- 500,000 shares at an average of $24.40 each, as reported on the form.
- No footnote on the form refers to a pre-arranged trading plan (Rule 10b5-1).
Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Jun 16, 2025InsiderOfficer sold ~$16K of BLFS shares in the open market
- Jul 7, 2025Insider · 5 peopleInsiders: 5 sales (~$52K)
- Jul 18, 2025InsiderOfficer sold ~$24K of BLFS shares in the open market
- Aug 11, 2025Insider10% owner sold ~$11.3M of BLFS shares in the open market
- Aug 15, 2025 · this disclosureInsider10% owner sold ~$12.2M of BLFS shares in the open market
What came next
- Aug 25, 2025InsiderOfficer sold ~$255K of BLFS shares in the open market
- Aug 26, 2025Insider · 6 peopleInsiders: 6 sales (~$56K)
- Sep 11, 2025Insider · 6 peopleInsiders: 6 sales (~$76K)
- Sep 15, 2025InsiderOfficer sold ~$18K of BLFS shares in the open market
- Oct 9, 2025Insider · 5 peopleInsiders: 5 sales (~$61K)
- Oct 15, 2025Insider10% owner sold ~$21.4M of BLFS shares in the open market
- Oct 20, 2025InsiderOfficer sold ~$7.7K of BLFS shares in the open market
- Oct 22, 2025InsiderCEO sold ~$1.03M of BLFS shares in the open market
- Oct 24, 2025InsiderDirector sold ~$48K of BLFS shares in the open market
- Nov 6, 2025Company filing · Form 8-K · ResultsReported its results
- Nov 11, 2025InsiderCEO sold ~$926K of BLFS shares in the open market
- Nov 12, 2025InsiderCEO sold ~$865K of BLFS shares in the open market
- Nov 13, 2025InsiderCEO sold ~$789K of BLFS shares in the open market
- Nov 19, 2025InsiderDirector sold ~$12K of BLFS shares in the open market
- Nov 20, 2025InsiderDirector sold ~$111K of BLFS shares in the open market
- Nov 21, 2025InsiderDirector sold ~$26K of BLFS shares in the open market
- Nov 25, 2025Insider · 7 peopleInsiders: 7 sales (~$113K)
- Nov 26, 2025InsiderDirector sold ~$54K of BLFS shares in the open market
- Dec 4, 2025InsiderCFO sold ~$772K of BLFS shares in the open market
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for BioLife Solutions, Inc.
For BioLife Solutions, Inc., OQRO holds 3 fund holdings reports (13F) and 1 federal contract award dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its BLFS page.
Other recent filings by Casdin Partners Master Fund, L.P., 10% owner
- SEC Form 4 at BioLife Solutions, Inc. (BLFS)May 21, 2026
- SEC Form 4 at BioLife Solutions, Inc. (BLFS)May 21, 2026
- SEC Form 4 at BioLife Solutions, Inc. (BLFS)May 21, 2026
- SEC Form 4 at BioLife Solutions, Inc. (BLFS)Oct 17, 2025
- SEC Form 4 at Standard Biotools (LAB)Sep 12, 2025
The full history of Casdin Partners Master Fund, L.P., 10% owner is on the profile page.
How this filing works
Explore the data
Common questions
Which BioLife Solutions, Inc. (BLFS) insider traded, and how much?
Casdin Partners Master Fund, 10% owner at BioLife Solutions, Inc., sold ~$12.2M of BioLife Solutions, Inc. shares. 500K shares at $24.40.
When did it happen, and when was it made public?
Traded: Aug 15, 2025. Filed: Aug 22, 2025. That is 7 days between the two dates.
What stands out in this filing?
After this sale the filing reports 6,707,165 shares, held indirectly. 500,000 shares at an average of $24.40 each, as reported on the form. No footnote on the form refers to a pre-arranged trading plan (Rule 10b5-1).
Is the dollar amount exact?
It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.
Where does this information come from?
From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about BioLife Solutions, Inc. recently?
For BioLife Solutions, Inc., OQRO holds 3 fund holdings reports (13F) and 1 federal contract award dated in the last 90 days. They are listed on the BLFS page.
Does this mean BLFS stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at BioLife Solutions, Inc.
- SEC Form 13F-HRNov 16, 2026
- SEC Schedule 13GNov 16, 2026
- SEC Form 13F-HRNov 13, 2026
- USAspending.gov award recordAug 31, 2026
- SEC Form 4May 21, 2026
- SEC Form 4May 21, 2026
Everything OQRO holds on this company is on its BLFS page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
